This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
{
"resourceType" : "MedicationAdministration",
"id" : "medication-administration-kadcyla",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b><a name=\"medication-administration-kadcyla\"> </a><a name=\"hcmedication-administration-kadcyla\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration "medication-administration-kadcyla" </p></div><p><b>status</b>: completed</p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>KADCYLA <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#1371046)</span></td></tr></table><p><b>subject</b>: <a href=\"Patient-patient-example-kaitlyn-b.html\">Patient/patient-example-kaitlyn-b</a> " BOUNCE"</p><p><b>occurence</b>: 2020-04-01</p><blockquote><p><b>performer</b></p><h3>Actors</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Practitioner-practitioner-oncology-nurse-jane.html\">Practitioner/practitioner-oncology-nurse-jane</a> " NURSE"</td></tr></table></blockquote><p><b>request</b>: <a href=\"MedicationRequest-medication-request-example-kadcyla.html\">MedicationRequest/medication-request-example-kadcyla</a></p><p><b>note</b>: 3.6mg administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/practitioner-oncology-nurse-jane @2020-04-01)</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style=\"display: none\">*</td><td>Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></td><td>3.6 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>"
},
"status" : "completed",
"medication" : {
"concept" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1371046",
"display" : "KADCYLA"
}
]
}
},
"subject" : {
🔗 "reference" : "Patient/patient-example-kaitlyn-b"
},
"occurenceDateTime" : "2020-04-01",
"performer" : [
{
"actor" : {
"reference" : {
🔗 "reference" : "Practitioner/practitioner-oncology-nurse-jane"
}
}
}
],
"request" : {
🔗 "reference" : "MedicationRequest/medication-request-example-kadcyla"
},
"note" : [
{
"authorReference" : {
🔗 "reference" : "Practitioner/practitioner-oncology-nurse-jane"
},
"time" : "2020-04-01",
"text" : "3.6mg administered by continuous infusion. Patient tolerated infusion without side effects."
}
],
"dosage" : {
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route (qualifier value)"
}
]
},
"dose" : {
"value" : 3.6,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}
}